Found 179 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
PHASE2This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Location
Multiple Locations
Perioperative Therapy for Hepatocellular Carcinoma
PHASE2This study aims to observe and evaluate the efficacy and safety of the peri...
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
N/AManagements for refractory proficient mismatch repair (pMMR) or microsatell...
Location
Hunan Cancer hospital
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
PHASE2Recently, a number of clinical studies were carried out to evaluate the the...
Location
Multiple Locations
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
PHASE1Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Location
the First Affiliated Hospital of Zhengzhou University
Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
PHASE2This is a single-arm, open-label and exploratory clinical study of Anlotini...
Location
Jiangsu Province Hospital
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial
PHASE3This is a randomized, controlled clinical trial based on prior exploratory ...
Location
Guangdong Provincial People's Hospital
The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.
PHASE2A single-center,prospective interventional study to explore the efficacy of...
Location
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University